Colorectal Cancer Clinical Trials in Miami, FL

View the best 10 colorectal cancer medical studies in Miami, Florida. Access promising new therapies by applying to a Miami-based Colorectal Cancer clinical trial.

Trials in Miami, Florida

Here are the top 10 medical studies for colorectal cancer in Miami, Florida

Michael Bask Gill, B Sc

Last Reviewed: December 17th, 2024

Phase 2 randomized: ELI-002 7P

Recruiting1 awardPhase 1 & 2

This trial is testing a new treatment called ELI-002 7P for patients with specific types of cancer. The treatment helps the immune system recognize and attack these cancer cells. ELI-002 7P targets mutations that are common in various cancers and have been studied for their role in tumor growth and resistance to treatments.

Treatment

Recruiting1 awardPhase 2

This trial will look at how well an imaging scan can detect and track cancer activity in people with solid tumors.

Encorafenib +1 More

Kinase Inhibitor

Recruiting2 awardsPhase 3

This trial is testing a new combination of drugs to treat colorectal cancer that has spread and has a certain type of abnormal gene. The new combination is encorafenib plus cetuximab, which will be taken either alone or with standard chemotherapy.

Irinotecan +4 More

Chemotherapy

Recruiting2 awardsPhase 3

"This trial is comparing using a special pump to deliver chemotherapy directly to the liver along with regular chemotherapy versus regular chemotherapy alone for patients with colorectal cancer that has spread to the liver and cannot be removed by

DAY101

MAPK Pathway Inhibitor

Recruiting1 awardPhase 1 & 2

This trial is testing Tovorafenib, a drug that blocks proteins needed for cancer cell growth, in patients aged 12+ with hard-to-treat melanoma or other solid tumors.

TAS-102 +2 More

Chemotherapy

Recruiting2 awardsPhase 3

This trial is testing a combination of two drugs, relatlimab and nivolumab, for patients with a certain type of colorectal cancer who haven't responded to other treatments. The drugs help the immune system attack the cancer.

Bevacizumab +3 More

Monoclonal Antibodies

Recruiting1 awardPhase 2

This trial tests a new drug, DKN-01, combined with standard chemotherapy and bevacizumab for advanced colorectal cancer patients who didn't respond to earlier treatment. The treatment works by attacking cancer cells, blocking growth signals, and cutting off their blood supply.

Sotorasib +1 More

Small Molecule Drug

Recruiting2 awardsPhase 3

This trial is testing two doses of sotorasib combined with panitumumab in patients with a specific type of colorectal cancer that has not responded to other treatments. Sotorasib targets a genetic mutation in the cancer cells, while panitumumab helps the immune system attack the cancer. The goal is to see if this combination can help patients live longer without their cancer getting worse.

AlloStim +1 More

Cancer Vaccine

Recruiting1 awardPhase 2

This trial is testing a new treatment for patients with advanced colorectal cancer who have not responded to standard chemotherapy or immunotherapy. They will receive a combination of a new immunotherapy drug called AlloSt

AlloStim

Cell Therapy

Recruiting1 awardPhase 2

This trial tests AlloStim, an immunotherapy using healthy donor immune cells, for patients with advanced colorectal cancer unresponsive to standard treatments. AlloStim helps train the patient's immune system to attack cancer cells by creating a temporary immune response.

Popular Filters

Phase 3 Trials

Small Molecule

MRTX849 + Cetuximab for Colorectal Cancer

Recruiting2 awardsPhase 3

Miami, Florida

This trial is testing a new treatment for patients with colorectal cancer. The treatment combines two drugs that work together to block cancer growth and prevent its spread. One of the drugs has shown promise in treating other types of cancer as well.

Kinase Inhibitor

Encorafenib + Cetuximab for Colorectal Cancer

Recruiting2 awardsPhase 3

Coral Gables, Florida

This trial is testing a new combination of drugs to treat colorectal cancer that has spread and has a certain type of abnormal gene. The new combination is encorafenib plus cetuximab, which will be taken either alone or with standard chemotherapy.

Alkylating agents

Nivolumab + Chemotherapy for Anal Cancer

Recruiting2 awardsPhase 3

Fort Lauderdale, Florida

This trial is testing whether adding nivolumab to standard chemotherapy is more effective for patients with metastatic anal cancer. Nivolumab helps the immune system fight cancer, while chemotherapy kills or stops cancer cells from growing. Nivolumab has shown significant effectiveness in treating metastatic squamous cell carcinoma of the anal canal.

PD-L1 Inhibitor

XL092 + Atezolizumab vs Regorafenib for Colorectal Cancer

Recruiting2 awardsPhase 3

Miami Beach, Florida

This trial is testing a combination of two drugs, XL092 and atezolizumab, against another treatment in patients with a specific type of colorectal cancer that has spread and not responded to standard treatments. The goal is to see if the new combination can better stop cancer growth and help the immune system fight the cancer.

Chemotherapy

Nivolumab-relatlimab Combo for Colorectal Cancer

Recruiting2 awardsPhase 3

Miami, Florida

This trial is testing a combination of two drugs, relatlimab and nivolumab, for patients with a certain type of colorectal cancer who haven't responded to other treatments. The drugs help the immune system attack the cancer.

Chemotherapy

Tucatinib + Trastuzumab + Chemotherapy for Colorectal Cancer

Recruiting2 awardsPhase 3

Miami Beach, Florida

This trial is testing to see if tucatinib in combination with other drugs is more effective than standard of care drugs at treating participants with HER2 positive colorectal cancer.

Trials With No Placebo

Interleukin-2 (IL-2) Agonist

MDNA11 + Pembrolizumab for Cancer

Recruiting1 awardPhase 1 & 2

Boca Raton, Florida

This trial is testing a new drug to treat cancer. The drug is given alone or with another drug. The study will see how well the drug works and how safe it is.

MAPK Pathway Inhibitor

Tovorafenib + Pimasertib for Cancer

Recruiting1 awardPhase 1 & 2

Miami, Florida

This trial is testing Tovorafenib, a drug that blocks proteins needed for cancer cell growth, in patients aged 12+ with hard-to-treat melanoma or other solid tumors.

Small Molecule

MRTX849 + Cetuximab for Colorectal Cancer

Recruiting2 awardsPhase 3

Miami, Florida

This trial is testing a new treatment for patients with colorectal cancer. The treatment combines two drugs that work together to block cancer growth and prevent its spread. One of the drugs has shown promise in treating other types of cancer as well.

Virus Therapy

T3011 + Pembrolizumab for Advanced Cancers

Recruiting1 awardPhase 1 & 2

Plantation, Florida

This trial is testing a new drug, T3011, to see if it's safe and effective in treating people with advanced solid tumors. The study will also compare T3011 given alone to T3011 given with another drug, pembrolizumab.

Kinase Inhibitor

Encorafenib + Cetuximab for Colorectal Cancer

Recruiting2 awardsPhase 3

Coral Gables, Florida

This trial is testing a new combination of drugs to treat colorectal cancer that has spread and has a certain type of abnormal gene. The new combination is encorafenib plus cetuximab, which will be taken either alone or with standard chemotherapy.

Small Molecule

PC14586 for Solid Tumors

Recruiting1 awardPhase 1 & 2

Miami, Florida

This trial is testing a new oral drug, PC14586 (rezatapopt), alone and with pembrolizumab, in patients with advanced cancers that have a specific genetic mutation. The drug aims to fix a mutated protein to help control cancer growth. The study will determine the best dose and evaluate the drug's safety and effectiveness.

View more colorectal-cancer clinical trials miami

See more medical studies focusing on colorectal-cancer miami

Frequently Asked Questions

Do I need insurance to participate in a trial?

Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).

Is there any support for travel costs?

Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.

Will I know what medication I am taking?

This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.

How long do clinical trials last?

Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.

Do you verify all the trials on your website?

All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.

How quickly will I hear back from a clinical trial?

Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.